Your browser is no longer supported. Please, upgrade your browser.
Settings
GRF Eagle Capital Growth Fund, Inc. daily Stock Chart
GRF [NYSE]
Eagle Capital Growth Fund, Inc.
Index- P/E5.50 EPS (ttm)1.37 Insider Own11.20% Shs Outstand3.70M Perf Week2.17%
Market Cap27.94M Forward P/E- EPS next Y- Insider Trans- Shs Float3.22M Perf Month-5.98%
Income5.20M PEG- EPS next Q- Inst Own6.80% Short Float0.04% Perf Quarter-5.73%
Sales0.40M P/S69.84 EPS this Y51.80% Inst Trans7.52% Short Ratio0.32 Perf Half Y-1.31%
Book/sh8.81 P/B0.86 EPS next Y- ROA- Target Price- Perf Year-5.62%
Cash/sh0.00 P/C- EPS next 5Y- ROE- 52W Range7.16 - 8.45 Perf YTD-4.92%
Dividend0.51 P/FCF- EPS past 5Y- ROI0.00% 52W High-10.65% Beta0.55
Dividend %6.75% Quick Ratio- Sales past 5Y- Gross Margin28.60% 52W Low5.45% ATR0.15
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)40.15 Volatility2.51% 1.66%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.61 Prev Close7.57
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume3.79K Price7.55
Recom- SMA20-2.47% SMA50-3.76% SMA200-2.86% Volume2,290 Change-0.30%
Oct-12-18 09:50AM  FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing PR Newswire
Oct-08-18 02:57PM  Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support PR Newswire
Sep-24-18 12:59PM  Grifols Announces the Opening of Biotest Pharmaceuticals Corporation's Newest Plasma Donor Center in Bowling Green, Ohio PR Newswire
Aug-14-18 08:00AM  Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System PR Newswire
May-31-18 09:00AM  Grifols Launches a New Testing Service for Patients Treated with Daratumumab PR Newswire
May-14-18 08:00AM  Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents PR Newswire
Apr-16-18 11:21AM  Grifols donates over 25 million international units of blood clotting factor in 2017 PR Newswire
Dec-28-17 04:15PM  Eagle Capital Growth Fund Finalizes Year-End Distribution of $0.51 Per Share Business Wire
Dec-04-17 08:00AM  Grifols Misterium® Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation PR Newswire
Nov-29-17 10:32AM  Kenya set to build coast-to-centre highway to boost Africa trade Reuters
Nov-06-17 04:15PM  Eagle Capital Growth Fund Declares Year-End Distribution of $0.51 Per Share Business Wire
Aug-22-17 08:00AM  Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces PR Newswire
Aug-01-17 08:00AM  Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol PR Newswire
Jul-28-17 02:50PM  Grifols SA : One of the better choices within its peer group Capital Cube
Jun-22-17 03:11PM  Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples PR Newswire
May-23-17 12:07PM  South Africa's Group Five names Mosai as new CEO Reuters
May-09-17 02:13PM  Grifols SA : Fairly valued, but dont skip the other factors Capital Cube
Apr-24-17 08:00AM  Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility PR Newswire
Apr-04-17 09:11AM  Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017 PR Newswire
09:11AM  Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017
Mar-08-17 04:16PM  Grifols SA : Fairly valued, but dont skip the other factors Capital Cube
04:16PM  Grifols SA : Fairly valued, but dont skip the other factors
Jan-31-17 04:05PM  Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million PR Newswire
04:01PM  Hologic Completes Divestiture of Blood Screening Business PR Newswire
Dec-28-16 04:01PM  Eagle Capital Growth Fund Finalizes Year-End Distribution of $1.19 Per Share Business Wire -5.58%
Dec-14-16 04:15PM  Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million PR Newswire
04:01PM  Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion PR Newswire
Nov-07-16 04:01PM  Eagle Capital Growth Fund Declares Year-End Distribution of $1.19 Per Share Business Wire
Sep-05-16 05:32AM  Grifols Opens Diagnostic Training Center in Dubai PR Newswire
Jul-22-16 03:18AM  Greiffenberger AG :GRF-DE: Earnings Analysis: For the six months ended December 31, 2015 : July 22, 2016 Capital Cube
03:18AM  Greiffenberger AG :GRF-DE: Earnings Analysis: For the six months ended December 31, 2015 : July 22, 2016
Jul-12-16 04:06PM  Grifols SA : Neutral outlook but great fundamentals Capital Cube
04:06PM  Grifols SA : Neutral outlook but great fundamentals
Jun-20-16 08:00AM  FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol PR Newswire
May-23-16 03:39AM  Greiffenberger AG :GRF-DE: Earnings Analysis: For the six months ended December 31, 2015 : May 23, 2016
May-10-16 11:36AM  CPV Power Plant No.1 Bond SPV (RF) Limited -- Moody's recalibrates South Africa's national rating scale and affirms Baa2.za rating of CPV Power Plant No.1 Bond SPV (RF) Limited; outlook stable at Moody's
11:36AM  CPV Power Plant No.1 Bond SPV (RF) Limited -- Moody's recalibrates South Africa's national rating scale and affirms Baa2.za rating of CPV Power Plant No.1 Bond SPV (RF) Limited; outlook stable at Moody's
Apr-28-16 04:05PM  Grifols SA : Neutral outlook but great fundamentals
Jan-27-16 07:44AM  Press Release, January 25, 2016 at noodls
Jan-26-16 07:29AM  Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV at noodls
07:29AM  Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV Download (249.7 Kb) at noodls
Dec-29-15 04:01PM  Eagle Capital Growth Fund Finalizes Year-End Distribution of $0.50 Per Share Business Wire
Nov-09-15 04:05PM  Eagle Capital Growth Fund Declares Year-End Distribution of $0.50 Per Share Business Wire
Oct-20-15 12:30PM  Grifols SA : Overvalued relative to peers, but may deserve another look
Aug-12-15 11:59AM  Grifols SA : Overvalued relative to peers, but good fundamentals
May-14-15 04:31PM  Grifols SA : Undervalued relative to peers?
Eagle Capital Growth Fund, Inc. is a closed-end equity mutual fund launched and managed by Sims Capital Management LLC. The fund invests in the public equity markets of the United States. It makes its investments in the stocks of companies operating across diversified sectors. The fund benchmarks the performance of its portfolio against the S&P 500 Index. It was previously known as NAIC Growth Fund, Inc. Eagle Capital Growth Fund, Inc. was formed on April 11, 1989 and is domiciled in the United States.